168 related articles for article (PubMed ID: 27443386)
1. Horner-Wadsworth-Emmons approach to piperlongumine analogues with potent anti-cancer activity.
Han LC; Stanley PA; Wood PJ; Sharma P; Kuruppu AI; Bradshaw TD; Moses JE
Org Biomol Chem; 2016 Aug; 14(31):7585-93. PubMed ID: 27443386
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z
Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol.
Xu X; Fang X; Wang J; Zhu H
Bioorg Med Chem Lett; 2017 Mar; 27(5):1325-1328. PubMed ID: 28159415
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells.
Kim YH; Yoon YJ; Lee YJ; Kim CH; Lee S; Choung DH; Han DC; Kwon BM
Bioorg Med Chem Lett; 2018 Aug; 28(14):2566-2572. PubMed ID: 29807795
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents.
Zou Y; Yan C; Zhang H; Xu J; Zhang D; Huang Z; Zhang Y
Eur J Med Chem; 2017 Sep; 138():313-319. PubMed ID: 28686911
[TBL] [Abstract][Full Text] [Related]
6. Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells.
Zhang Y; Ma H; Wu Y; Wu Z; Yao Z; Zhang W; Zhuang C; Miao Z
Bioorg Med Chem Lett; 2017 Jun; 27(11):2308-2312. PubMed ID: 28434764
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
Lad NP; Kulkarni S; Sharma R; Mascarenhas M; Kulkarni MR; Pandit SS
Eur J Med Chem; 2017 Jan; 126():870-878. PubMed ID: 27987486
[TBL] [Abstract][Full Text] [Related]
9. Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review.
Piska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Pękala E
Eur J Med Chem; 2018 Aug; 156():13-20. PubMed ID: 30006159
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization and biological evaluation of 4'-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides.
Franchini S; Battisti UM; Sorbi C; Tait A; Cornia A; Jeong LS; Lee SK; Song J; Loddo R; Madeddu S; Sanna G; Brasili L
Arch Pharm Res; 2017 May; 40(5):537-549. PubMed ID: 27615010
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
[TBL] [Abstract][Full Text] [Related]
12. Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation.
Liu X; Wang Y; Zhang X; Gao Z; Zhang S; Shi P; Zhang X; Song L; Hendrickson H; Zhou D; Zheng G
Bioorg Med Chem; 2018 Aug; 26(14):3925-3938. PubMed ID: 29925484
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine B and analogs are promising and selective inhibitors for acetylcholinesterase.
Wiemann J; Karasch J; Loesche A; Heller L; Brandt W; Csuk R
Eur J Med Chem; 2017 Oct; 139():222-231. PubMed ID: 28802122
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents.
Meegan MJ; Nathwani S; Twamley B; Zisterer DM; O'Boyle NM
Eur J Med Chem; 2017 Jan; 125():453-463. PubMed ID: 27689728
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.
Punganuru SR; Madala HR; Venugopal SN; Samala R; Mikelis C; Srivenugopal KS
Eur J Med Chem; 2016 Jan; 107():233-44. PubMed ID: 26599530
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of apoptolidin: completion of the synthesis and analogue synthesis and evaluation.
Nicolaou KC; Li Y; Sugita K; Monenschein H; Guntupalli P; Mitchell HJ; Fylaktakidou KC; Vourloumis D; Giannakakou P; O'Brate A
J Am Chem Soc; 2003 Dec; 125(50):15443-54. PubMed ID: 14664590
[TBL] [Abstract][Full Text] [Related]
17. 12,13-Aziridinyl Epothilones. Stereoselective Synthesis of Trisubstituted Olefinic Bonds from Methyl Ketones and Heteroaromatic Phosphonates and Design, Synthesis, and Biological Evaluation of Potent Antitumor Agents.
Nicolaou KC; Rhoades D; Wang Y; Bai R; Hamel E; Aujay M; Sandoval J; Gavrilyuk J
J Am Chem Soc; 2017 May; 139(21):7318-7334. PubMed ID: 28513142
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer evaluation of spermatinamine analogues.
Moosa BA; Sagar S; Li S; Esau L; Kaur M; Khashab NM
Bioorg Med Chem Lett; 2016 Mar; 26(6):1629-1632. PubMed ID: 26874403
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs.
Adams DJ; Dai M; Pellegrino G; Wagner BK; Stern AM; Shamji AF; Schreiber SL
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15115-20. PubMed ID: 22949699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
